Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Clinical Trials (London, England)|December 13, 2012
Cost-utility analysis conducted alongside randomized controlled trials: are economic end points considered in sample size calculations and does it matter?William Hollingworth, Denise McKell-Redwood, Lisa Hampson, et al.Journal of Biopharmaceutical Statistics|November 21, 2007
A Bayesian approach for dose-escalation in a Phase I clinical trial incorporating pharmacodynamic endpointsJohn Whitehead, Yinghui Zhou, Lisa Hampson, et al.Therapeutic Innovation & Regulatory Science|May 16, 2019
Incorporating Innovative Techniques Toward Extrapolation and Efficient Pediatric Drug DevelopmentMargaret Gamalo-Siebers, Lisa Hampson, Kattayoun Kordy, et al.Physiotherapy|December 4, 2012
Exercise and self-management for people with chronic knee, hip or lower back pain: a cluster randomised controlled trial of clinical and cost-effectiveness. Study protocolNicola Walsh, Fiona Cramp, Shea Palmer, et al.Therapeutic Innovation & Regulatory Science|June 19, 2018
Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials: Review of Methods and OpportunitiesJessica Lim, Rosalind Walley, Jiacheng Yuan, et al.Statistics in Biopharmaceutical Research|June 30, 2021
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19Nigel Stallard, Lisa Hampson, Norbert Benda, et al.Pilot and Feasibility Studies|March 31, 2017
Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trialDaniel Hind, James Parkin, Victoria Whitworth, et al.Health Technology Assessment (Winchester, England)|June 20, 2017
Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluationDaniel Hind, James Parkin, Victoria Whitworth, et al.Pageof 1